Advertisement

Regional Perfusion with cis-Platinum and Dacarbazine

  • K. Aigner
  • P. Hild
  • K. Henneking
  • E. Paul
  • M. Hundeiker
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 86)

Abstract

In October 1979, the isolated extremity perfusion for treatment of malignant melanomas and sarcomas was introduced in Giessen. Improvements in perfusion technique have been incorporated in the method continuously. Within the first 2½ years 190 extremity perfusions were performed. The drug combination most commonly used was melphalan with dactinomycin. Besides this we started using nitrogen mustard, and after having worked out the dosage schedules in animal experiments we introduced dacarbazine and cis-platinum for isolation perfusion.

Keywords

Nitrogen Mustard Regional Perfusion Cutaneous Metastasis Isolation Perfusion Hyperthermic Perfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aigner K, Schwemmle K (to be published) Technik der isolierten Extremitätenperfusion. Langenbecks Arch ChirGoogle Scholar
  2. Aigner K, Hild P, Henneking K, Paul E, Hundeiker M, Breithaupt H, Merker G, Jungbluth A (1980) DTIC — Studies in isolated perfusion of the leg and the liver in dogs. EORTC Melanoma Meeting, Lausanne 24/25 April 1980Google Scholar
  3. Aigner K, Hild P, Breithaupt H, Hundeiker M, Schwemmle K, Henneking K, Illig L, Merker G, Paul E, Brodkorb J, Jungbuth A (to be published) The isolated extremity perfusion with DTIC — an experimental and clinical study. Anticancer ResGoogle Scholar
  4. Biscoping J, Aigner K, Hempelmann G (1982) Erfahrungen mit einer kontinuierlichen Plexus-Anaesthesie des Armes nach Melanomperfusion. Region Anaesth 5: 62–63Google Scholar
  5. Krementz ET, Ryan RF (1972) Chemotherapy of melanoma of the extremities by perfusion: fourteen years’ clinical experience. Ann Surg 175: 900PubMedCrossRefGoogle Scholar
  6. Lejeune FJ, DeWasch G (1978) Malignant melanoma. In: Staquet MJ (ed) Randomized trials in cancer: a critical review by sites. Raven, New York, p 339Google Scholar
  7. Luce JK (1972) Chemotherapy of malignant melanoma. Cancer 30: 1604PubMedCrossRefGoogle Scholar
  8. Martijn H, Oldhoff J, Schraffordt Koops H (1981) Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limb. Eur J Cancer 17: 471PubMedCrossRefGoogle Scholar
  9. McBride CM (1970) Advanced melanoma of the extremities. Treatment by isolation perfusion with a triple drug combination. Arch Surg 101: 122PubMedCrossRefGoogle Scholar
  10. Schraffordt Koops H, Beekhuis H, Oldhoff J, Oosterhius JW, van der Ploeg E, Vermey A (1981) Local recurrence and survival in patients with (Clark level IV/V and over 1.5 mm thickness) stage I malignant melanoma of the extremities after regional perfusion. Cancer 48: 1952PubMedCrossRefGoogle Scholar
  11. Stehlin JS, Giovanella BC, de Ipolye PD, Muenz LR, Anderson RF (1975) Results of hyperthermie perfusion for melanoma of the extremities. Surg Gynecol Obstet 140: 338Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1983

Authors and Affiliations

  • K. Aigner
    • 1
  • P. Hild
    • 1
  • K. Henneking
    • 1
  • E. Paul
    • 1
  • M. Hundeiker
    • 1
  1. 1.Allgemeinchirurgische Klinik des Zentrums für ChirurgieJustus-Liebig-UniversitätGiessenGermany

Personalised recommendations